Recursive Adaptation - Addiction Medicine and Policy

Recursive Adaptation - Addiction Medicine and Policy

Home
CASPR.org
Archive
About
Caron Center launches GLP-1 for addiction program supported by CASPR
Novel program will integrate GLP-1 receptor agonist (GLP-1RA) therapy into residential treatment programs for individuals in early recovery
 • 
Nicholas Reville
My podcast episode with Chris Hayes
Chris interviewed me about addiction medicine, GLP-1s, and innovation policy.
 • 
Nicholas Reville
GLP-1s for Reducing Addiction: Everything you need to know
The science, medicine, patient experiences, provider experiences, policy, and more.
 • 
Nicholas Reville
4
A Uniquely High Leverage Opportunity for Philanthropy
Solving addiction is achievable and has a higher ROI than nearly any charitable initiative.
 • 
Nicholas Reville
2
Semaglutide for AUD / OUD: BRIDGE Launches at Caron Treatment Centers
15 patients are already receiving semaglutide as part of their treatment program.
 • 
Nicholas Reville
Most Popular
View all
GLP-1 for Addiction: the Medical Evidence for Opioid, Nicotine, and Alcohol Use Disorder
 • Nicholas Reville and Zarinah Agnew
1
Addiction Predictions for 2025 and Beyond
 • Nicholas Reville
17
Wegovy and Ozempic (semaglutide) are associated with a 50-56% reduction in alcohol addiction
 • Nicholas Reville
4
An Innovation Agenda for Addiction
 • Nicholas Reville and Will
To receive all of our articles by email, subscribe now (it's free!)

Recent posts

View all
Semaglutide, however you can get it
Documentary opportunity, opioids + stimulants, and more news
 • 
Nicholas Reville
"Post-GLP-1 shot, I could physically feel the desire cravings leave my head."
A shopping addiction and alcohol addiction disappeared with semaglutide.
 • 
Noah Davis
1
Cannabis and psychosis, PRV for addiction, vaping, and endpoints
Addiction news and updates
 • 
Nicholas Reville
2
Do GLP-1s reduce drug or alcohol withdrawal symptom severity?
5 stories from patients.
 • 
Noah Davis
How CASPR is helping advance next generation addiction medicine
Trials and programs that CASPR is running or making possible.
 • 
Nicholas Reville
Semaglutide compounding is being shut down– can a gummies hack keep it alive?
And will patients turn on Trump and RFK as hundreds of thousands lose access to GLP-1s?
 • 
Nicholas Reville
1
© 2025 CASPR
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture